ETHOSUXIMIDE solution United States - English - NLM (National Library of Medicine)

ethosuximide solution

versapharm incorporated - ethosuximide (unii: 5seh9x1d1d) (ethosuximide - unii:5seh9x1d1d) - ethosuximide 250 mg in 5 ml - ethosuximide is indicated for the control of absence (petit mal) epilepsy. ethosuximide should not be used in patients with a history of hypersensitivity to succinimides.

LINDANE lotion United States - English - NLM (National Library of Medicine)

lindane lotion

versapharm incorporated - lindane (unii: 59nee7pcab) (lindane - unii:59nee7pcab) - lindane 10 mg in 1 ml - lindane lotion is indicated for the treatment of scabies (infestations of sarcoptes scabei ) only in patients who: - cannot tolerate other approved therapies, or - have failed treatment with other approved therapies. lindane lotion should be used in the context of an overall scabies management program that includes: - microscopic evaluation of skin scrapings to confirm the diagnosis. - evaluation and treatment of sexual contacts simultaneously. sexual contacts should be prescribed lindane lotion only if they either have failed to respond to adequate doses of other approved therapies or are intolerant of other approved therapies. - washing of all recently worn clothing, underwear, pajamas, used sheets, pillowcases, and towels in very hot water or dry-cleaned. caregivers applying this product to patients should wear gloves less permeable to lindane, such as nitrile, latex with neoprene, or sheer vinyl, and thoroughly clean hands after application. natural latex gloves should be avoided because they are more pe

LINDANE shampoo United States - English - NLM (National Library of Medicine)

lindane shampoo

versapharm incorporated - lindane (unii: 59nee7pcab) (lindane - unii:59nee7pcab) - lindane 10 mg in 1 ml - lindane shampoo is indicated for the treatment of head lice (infestations of pediculosis humanis capitis ), crab lice (infestations of pthirus pubis ), and their ova only in patients who - cannot tolerate other approved therapies, or - have failed treatment with other approved therapies. lindane shampoo should be used in the context of an overall lice management program that includes: - visual inspection to ensure that the patient is currently infested with live lice (empty egg casings or "nits" can remain on hair shaft long after true infestation). - manual removal of nits using a comb designed for this purpose and/or individual removal with tweezers followed by close examination of the hair and scalp. - evaluation and treatment of sexual contacts simultaneously. sexual contacts should be prescribed lindane shampoo only if they either have failed to respond to adequate doses of other approved therapies or are intolerant of other approved therapies. - all recently worn clothing, underwear, pajamas, used sheet

TRIAMCINOLONE ACETONIDE lotion United States - English - NLM (National Library of Medicine)

triamcinolone acetonide lotion

versapharm incorporated - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 0.25 mg in 1 ml - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

ISONARIF- rifampin and isoniazid capsule United States - English - NLM (National Library of Medicine)

isonarif- rifampin and isoniazid capsule

versapharm incorporated - rifampin (unii: vjt6j7r4tr) (rifampin - unii:vjt6j7r4tr), isoniazid (unii: v83o1voz8l) (isoniazid - unii:v83o1voz8l) - rifampin 300 mg - for pulmonary tuberculosis in which organisms are susceptible, and when the patient has been titrated on theindividual components and it has therefore been established that this fixed dosage is therapeutically effective. this fixed-dosage combination drug is not recommended for initial therapy of tuberculosis or for preventive therapy. in the treatment of tuberculosis, small numbers of resistant cells, present within large populations of susceptiblecells, can rapidly become the predominating type. since rapid emergence of resistance can occur, culture andsusceptibility tests should be performed in the event of persistent positive cultures. this drug is not indicated for the treatment of meningococcal infections or asymptomatic carriers of n. meningitides to eliminate meningococci from the nasopharynx. previous isoniazid-associated hepatic injury; severe adverse reactions to isoniazid, such as drug fever, chills, andarthritis; acute liver disease of any etiology. a history of previous hypersensitivity reactio

NYSTATIN AND TRIAMCINOLONE ACETONIDE ointment United States - English - NLM (National Library of Medicine)

nystatin and triamcinolone acetonide ointment

versapharm incorporated - nystatin (unii: bdf1o1c72e) (nystatin - unii:bdf1o1c72e), triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - nystatin 100000 [usp'u] in 1 g - nystatin and triamcinolone acetonide ointment is indicated for the treatment of cutaneous candidiasis. it has been demonstrated that the nystatin-steroid combination provides greater benefit than the nystatin component alone during the first few days of treatment. this preparation is contraindicated in those patients with a history of hypersensitivity to any of its components.

BETAMETHASONE DIPROPIONATE lotion United States - English - NLM (National Library of Medicine)

betamethasone dipropionate lotion

versapharm incorporated - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone dipropionate lotion, usp 0.05% w/w is a medium-potency corticosteroids indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years and older. betamethasone dipropionate lotion, usp 0.05% w/w is contraindicated in those patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any of the components in these preparation.

TRIAMCINOLONE ACETONIDE aerosol, spray United States - English - NLM (National Library of Medicine)

triamcinolone acetonide aerosol, spray

versapharm incorporated - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 0.147 mg in 1 g - triamcinolone acetonide topical aerosol, usp is indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

DESOXIMETASONE gel United States - English - NLM (National Library of Medicine)

desoximetasone gel

versapharm incorporated - desoximetasone (unii: 4e07gxb7au) (desoximetasone - unii:4e07gxb7au) - desoximetasone 0.5 mg in 1 g - desoximetasone gel 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

ERYTHROMYCIN solution United States - English - NLM (National Library of Medicine)

erythromycin solution

versapharm incorporated - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - erythromycin 20 mg in 1 ml - erythromycin pledgets usp, 2% are indicated for the topical treatment of acne vulgaris. erythromycin pledgets usp, 2% are contraindicated in those individuals who have shown hypersensitivity to any of its components.